SYNG Pharmaceuticals Inc
Research - Kingston, Ontario, Canada
SYNG Pharmaceuticals Inc Employees
SYNG Pharmaceuticals Inc Details
SYNG Pharmaceuticals Inc. (SYNG Pharma) is a pre-clinical stage biotechnology company dedicated to developing next generation diagnostic and therapeutic against endometriosis. The company is developing a novel peptide, SP011, to inhibit a target now known for its role in the proliferation of cells. SYNG Pharma has a potential to develop a treatment that would be a much needed alternative to currently available, partly ineffective, hormonal therapy. There are many other potential applications of SYNG Pharma technology including the treatment of fibroids and uterine sarcoma; breast and prostate cancer which may be further developed depending upon corporate interests and an opportunity for partnership.
SYNG Pharmaceuticals Inc Technologies
Email Providers
Gmail
CMS
Wix
Other
Mobile Friendly
Hosting
Google Cloud Hosting
Online Video Platforms
YouTube